灵康药业
(603669)
| 流通市值：27.91亿 | | | 总市值：27.91亿 |
| 流通股本：7.21亿 | | | 总股本：7.21亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 150,665,541.41 | 112,920,840.32 | 73,303,587.38 | 289,263,184.49 |
| 营业收入 | 150,665,541.41 | 112,920,840.32 | 73,303,587.38 | 289,263,184.49 |
| 二、营业总成本 | 255,792,111.55 | 181,133,436.74 | 94,993,229.26 | 457,425,555.63 |
| 营业成本 | 79,250,028.36 | 57,421,032.06 | 27,550,894.23 | 93,115,327.04 |
| 税金及附加 | 3,137,158.44 | 2,366,410.4 | 1,407,778.85 | 6,304,727.84 |
| 销售费用 | 89,028,693.86 | 67,154,711.88 | 44,180,548.18 | 236,618,674.65 |
| 管理费用 | 62,718,810.45 | 40,615,541.75 | 18,275,835.74 | 90,914,842.96 |
| 研发费用 | 21,226,696.58 | 13,301,203.59 | 3,470,253.82 | 31,625,031.75 |
| 财务费用 | 430,723.86 | 274,537.06 | 107,918.44 | -1,153,048.61 |
| 其中:利息费用 | 2,944,346.85 | 2,016,438.17 | 1,157,014.64 | 5,831,661.5 |
| 其中:利息收入 | 2,582,484.66 | 1,786,625.61 | 1,082,120.26 | 7,107,888.46 |
| 加:公允价值变动收益 | -8,600,627.79 | -2,910,964 | -2,214,232.77 | 1,215,816.05 |
| 加:投资收益 | -3,247,612.96 | -2,147,846.16 | 2,254,549.91 | -9,334,505.77 |
| 资产处置收益 | 86,342.29 | 86,342.29 | - | 446,661.99 |
| 资产减值损失(新) | -1,989,226.07 | -210,035.56 | -123,883.5 | -9,006,306.56 |
| 信用减值损失(新) | -8,659,574.01 | -625,724.21 | -1,024,858.63 | -6,936,806.47 |
| 其他收益 | 33,544,142.03 | 6,256,567.69 | 1,798,072.28 | 3,102,139.33 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -93,993,126.65 | -67,764,256.37 | -20,999,994.59 | -188,675,372.57 |
| 加:营业外收入 | 214,809.05 | 214,808.71 | 5.28 | 2,812.83 |
| 减:营业外支出 | 2,042,525.38 | 1,267,968.64 | 191,352.57 | 133,336.72 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -95,820,842.98 | -68,817,416.3 | -21,191,341.88 | -188,805,896.46 |
| 减:所得税费用 | 761,657.87 | 903,921.06 | 1,800,035.63 | 6,941,824.18 |
| 六、净利润 | -96,582,500.85 | -69,721,337.36 | -22,991,377.51 | -195,747,720.64 |
| 持续经营净利润 | -96,582,500.85 | -69,721,337.36 | -22,991,377.51 | -195,747,720.64 |
| 归属于母公司股东的净利润 | -96,582,500.85 | -69,721,337.36 | -22,991,377.51 | -195,747,720.64 |
| (一)基本每股收益 | -0.13 | -0.1 | -0.03 | -0.27 |
| (二)稀释每股收益 | -0.13 | -0.1 | -0.03 | -0.25 |
| 九、综合收益总额 | -96,582,500.85 | -69,721,337.36 | -22,991,377.51 | -195,747,720.64 |
| 归属于母公司股东的综合收益总额 | -96,582,500.85 | -69,721,337.36 | -22,991,377.51 | -195,747,720.64 |
| 公告日期 | 2023-10-21 | 2023-08-26 | 2023-04-29 | 2023-04-22 |
| 审计意见(境内) | | | | 标准无保留意见 |